About MxBiodevices

About company

MxBiodevices was founded in August 2009 specifically to commercialize an injectable nano scaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU’s) and other chronic wounds. The company's founders were instrumental in E-Matrix development over the last 12 plus years, which led to 6 commercially successful E-Matrix products in orthopedics and spine. In February 2012 MxBiodevices obtained the exclusive license for E-Matrix treatment of all chronic wounds including DFU’s, decubitus ulcers, venous stasis ulcers, and surgical adhesions. The company has completed two FDA IDE clinical studies of E-Matrix treatment of DFU’s.